Synthetic Human Calcitonin in Refractory Paget’s Disease of Bone

Roy D. Altman, Barbara Collins Yudiskas

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Fourteen patients with symptomatic and active Paget’s disease of bone who had demonstrated resistance to parenteral synthetic salmon calcitonin, oral disodium etidronate, or both in combination were treated with parenteral synthetic human calcitonin. Eleven patients (79%) demonstrated clinical and chemical improvement for up to five years. Two patients received additional benefit with combined synthetic human calcitonin and etidronate disodium.

Original languageEnglish (US)
Pages (from-to)1305-1308
Number of pages4
JournalArchives of internal medicine
Issue number7
StatePublished - Jul 1987

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Synthetic Human Calcitonin in Refractory Paget’s Disease of Bone'. Together they form a unique fingerprint.

Cite this